Erythropoietic protoporphyria and afamelanotide: a patient's perspective

Clin Exp Dermatol. 2024 Jan 25;49(2):186-187. doi: 10.1093/ced/llad346.
No abstract available

MeSH terms

  • Humans
  • Protoporphyria, Erythropoietic* / complications
  • Protoporphyria, Erythropoietic* / drug therapy
  • alpha-MSH

Substances

  • afamelanotide
  • alpha-MSH